ID: ALA4777949

Max Phase: Preclinical

Molecular Formula: C11H7FN2O3

Molecular Weight: 234.19

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=[N+]([O-])c1ccc(Oc2ccc(F)cc2)nc1

Standard InChI:  InChI=1S/C11H7FN2O3/c12-8-1-4-10(5-2-8)17-11-6-3-9(7-13-11)14(15)16/h1-7H

Standard InChI Key:  WGCAKTXIGRVECX-UHFFFAOYSA-N

Associated Targets(Human)

Heat shock protein beta-1 172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 234.19Molecular Weight (Monoisotopic): 234.0441AlogP: 2.92#Rotatable Bonds: 3
Polar Surface Area: 65.26Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.93CX LogD: 2.93
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.60Np Likeness Score: -2.25

References

1. Makley LN,Johnson OT,Ghanakota P,Rauch JN,Osborn D,Wu TS,Cierpicki T,Carlson HA,Gestwicki JE.  (2021)  Chemical validation of a druggable site on Hsp27/HSPB1 using in silico solvent mapping and biophysical methods.,  34  [PMID:33549906] [10.1016/j.bmc.2020.115990]

Source